United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 669,200 | 705,100 | 1,023,000 | 831,800 | 397,697 |
| Marketable Securities | 746,700 | 222,300 | 27,800 | 122,000 | 297,842 |
| Receivables | 175,700 | 297,100 | 214,500 | 192,800 | 162,287 |
| Inventories | 101,000 | 107,900 | 100,000 | 81,300 | 66,927 |
| Other current assets | 75,400 | 115,500 | 59,500 | 47,400 | 32,836 |
| TOTAL | $1,768,000 | $1,447,900 | $1,424,800 | $1,275,300 | $957,589 |
| Non-Current Assets | |||||
| PPE Net | 699,700 | 545,700 | 489,300 | 495,800 | 478,421 |
| Investments And Advances | 442,600 | 502,700 | 2,300 | 38,000 | 122,658 |
| Intangibles | 0 | 0 | 0 | 0 | 29,465 |
| Other Non-Current Assets | 490,700 | 383,100 | 409,200 | 375,300 | 296,277 |
| TOTAL | $1,633,000 | $1,431,500 | $900,800 | $909,100 | $926,821 |
| Total Assets | $3,401,000 | $2,879,400 | $2,325,600 | $2,184,400 | $1,884,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | N/A | N/A | N/A | 126,414 |
| Accounts payable and accrued liabilities | 166,100 | 171,100 | 104,200 | 103,400 | 85,382 |
| Other current liabilities | 110,500 | 273,600 | 228,300 | 337,300 | 292,514 |
| TOTAL | $276,600 | $444,700 | $332,500 | $440,700 | $504,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 250,000 | 250,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 85,800 | 82,900 | 141,800 | 155,100 | 137,744 |
| TOTAL | $335,800 | $332,900 | $141,800 | $155,100 | $137,744 |
| Total Liabilities | $612,400 | $777,600 | $474,300 | $595,800 | $642,054 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,722 | 43,240 | 44,962 | 45,353 | 46,666 |
| Common Shares | 700 | 700 | 700 | 700 | 660 |
| Retained earnings | 3,434,800 | 2,845,600 | 2,433,500 | 1,719,800 | 1,068,114 |
| Other shareholders' equity | -8,100 | -19,800 | -16,400 | -20,500 | -16,559 |
| TOTAL | $2,788,600 | $2,101,800 | $1,851,300 | $1,588,600 | $1,242,356 |
| Total Liabilities And Equity | $3,401,000 | $2,879,400 | $2,325,600 | $2,184,400 | $1,884,410 |